Evoke Wealth, LLC Biogen Inc. Transaction History

Evoke Wealth, LLC

$84.8 Billion
Q2 2024

A detailed history of Evoke Wealth, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Evoke Wealth, LLC holds 3,540 shares of BIIB stock, worth $615,216. This represents 0.97% of its overall portfolio holdings.

Number of Shares

3,540

Previous 10,828 67.31%

Holding current value

$615,216

Previous $2.33 Million 35060.37%

% of portfolio

0.97%

Previous 0.07%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $1.39 Million - $1.73 Million	-7,288 Reduced 67.31%	3,540 $821 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $4,876 - $6,157	-23 Reduced 0.21%	10,828 $2.33 Million
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $2.42 Million - $2.91 Million	10,851 New	10,851 $2.81 Million
Q1 2023 May 08, 2023	BUY	$256.56 - $292.34 $1,282 - $1,461	5 Added 0.07%	7,069 $1.97 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $1.78 Million - $2.17 Million	7,064 New	7,064 $1.96 Million
Q2 2022 Aug 04, 2022	SELL	$187.54 - $223.02 $67,889 - $80,733	-362 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$193.77 - $244.14 $62,781 - $79,101	324 Added 852.63%	362 $76,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $3,395 - $4,428	-12 Reduced 24.0%	38 $10,000
Q2 2021 Aug 05, 2021	BUY	$259.0 - $414.71 $1,295 - $2,073	5 Added 11.11%	50 $17,000
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $775 - $1,027	-3 Reduced 6.25%	45 $12,000
Q1 2020 May 07, 2020	SELL	$268.85 - $341.04 $105,389 - $133,687	-392 Reduced 89.09%	48 $15.2 Million
Q4 2019 Feb 07, 2020	SELL	$220.06 - $304.07 $164,384 - $227,140	-747 Reduced 62.93%	440 $131 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $258,101 - $289,485	1,187 New	1,187 $276 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evoke Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evoke Wealth, LLC with notifications on news.

Account